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As they ﬁrst pointed, we agree that there are evident para-
doxes in the attitude of our societies toward alcohol consump-
tion. On the one hand, alcohol drinking is largely encouraged,
namely by advertising campaigns, and moderate or ‘‘controlled’’
drinking remains a mark of social integration. On the other hand,
addictive drinking still leads to global moral disapproval and
social exclusion, alcoholic patients being considered as responsi-
ble for their disease. Testino and Borro also underlined that global
judgment of the alcoholism based on the severity of the liver dis-
ease could lead to unfair patient categorization as similar alcohol
consumptions could lead to very different outcomes in different
individuals, according to genetic backgrounds [2] and/or other
risk factors.
As the authors stated, we also consider that moral and societal
appreciations strongly inﬂuence the entire debate about liver
transplantation (LT) in alcoholic liver diseases and particularly
in patients with severe alcoholic hepatitis (SAH). Of course, the
discussion about LT in these patients is dramatically exacerbated
in the current context of organ shortage. On ethical grounds how-
ever, we would like to suggest that the transplant community has
the duty to regularly evaluate and re-evaluate the rules for organ
allocation, aiming at ensuring the optimal use of a scarce thera-
peutic resource. The deﬁnition of the optimal graft use in this
context remains debatable but, based on fundamental ethical
principles, we propose that the primary aim of organ transplanta-
tion should be a life-saving procedure, in the absence of any other
therapeutic alternative, leading to satisfactory long-term results
such as long-term graft and patient survivals. Optimally, deci-
sional algorithms should be based on objective and transparent
data, independently from any moral, societal or cultural inﬂu-
ences. In parallel, the indications for LT should not be considered
as deﬁnitively established, and, we could expect that in the next
years, better disease understanding and therapeutic advances in
alcohol liver diseases but also in other conditions, such as in hep-
atitis C or in hepatocellular carcinoma, will signiﬁcantly modify
the listing strategies, both to restrict or to enlarge the inclusion
criteria.
At this stage, of course, early LT in patients with SAH remains
a challenging procedure. A ﬁrst step has been made with an ini-
tial report showing satisfactory results in highly selected patients
[3]. Yet, these ﬁrst results have now to be conﬁrmed in strictJournal of Hepatology 20
Open access under CC BY-NC-ND license.investigational frameworks, with longer follow-up and in larger
patient population. In this process, the deﬁnition of accurate
selection criteria has a critical importance. In that sense, it should
be mentioned that a multicentre prospective study has been initi-
ated, to identify and to validate various selection criteria [4].
Among these factors, we fully agree with Testino and Borro that
familial and socio-professional environments, attendance to self-
help groups and cooperation with alcohol units play a pivotal role.
We are convinced that a door has now been opened to pro-
pose LT in selected patients with SAH. Careful evaluation of the
selection criteria and analysis of the long-term results, including
overall survivals, analysis of alcohol relapses, eventually leading
to subsequent graft damages, will constitute the next steps to
fully validate this procedure.14 vol. 61 j 706–716 707
